Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.
Opinion
Case: 21-1926 Document: 48 Page: 1 Filed: 03/09/2022
NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit
______________________
AZURITY PHARMACEUTICALS, INC.,
Plaintiff-Appellant v. BIONPHARMA INC., Defendant-Appellee ______________________ 2021-1926, 2021-1927 ______________________
Appeals from the United States District Court for the District of Delaware in Nos. 1:18-cv-01962-LPS, 1:19- cv-01067-LPS, Judge Leonard P. Stark.
______________________ JUDGMENT ______________________
RICHARD TORCZON, Wilson, Sonsini, Goodrich & Rosati, PC, Washington, DC, argued for plaintiff-appellant. Also represented by TY WILLIAM CALLAHAN, GRANVILLE CLAYTON KAUFMAN, Los Angeles, CA; WENDY L. DEVINE, NICHOLAS SYLVESTER HALKOWSKI, KRISTINA M. HANSON, San Francisco, CA; NATALIE J. MORGAN, San Diego, CA.
ANDREW M. ALUL, Taft, Stettinius & Hollister, LLP, Chicago, IL, argued for defendant-appellee. Also repre- sented by ROSHAN SHRESTHA.
Case: 21-1926 Document: 48 Page: 2 Filed: 03/09/2022
______________________
THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:
PER CURIAM (NEWMAN, CLEVENGER, and STOLL, Cir- cuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY ORDER OF THE COURT March 9, 2022 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner
Clerk of Court
Case-law data current through September 30, 2026. Source: CourtListener bulk data.